Search Results

240 results for PDLI

10 Biotechnology Stocks to Sell Now

This week, the ratings of 10 Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

5 Hidden Dividend Gems to Buy Now

Sometimes juicy dividends come in small packages. Take a look at these five lesser-known small-cap dividend stocks yielding 6% or more.

4 Penny Stocks to Own for 2019

Too many stocks started 2018 out at prices that were simply too high. Not these names though. These penny stocks are still dirt cheap, but…

The ‘Magic Formula’ Whips Up 5 More Value Stocks

The Magic Formula — a list of highly profitable companies trading at cheap valuations — has added five new value stocks and dumped five.

4 Tempting Dividends You MUST Resist

Don’t get sucked in by these 4 dividend stocks. Behind their eye-popping yields lies the potential for disaster.

9 Top Pharmaceutical Stocks to Buy for the Dividends

Fans of dividends don’t have to completely abandon all hope for growth too — these top pharmaceutical stocks offer the best of both worlds.

19 Biotechnology Stocks to Sell Now

This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

4 Heavily Shorted Dividend Stocks to Sell

These four heavily shorted dividend stocks might offer up sweet payouts, but investors are still better off avoiding them.

6 Stocks That Could Double in 2011

The stocks on this list could deliver 100% returns in the next 12 months.

6 Stocks That Could Double in the Next Year

100% profits by 2011 is not impossible with these potential money-doubling stock picks.

4 Dangerous Dividend Stocks to Avoid for Retirement

A high-yield stock may look mighty tempting to buy for retirement. But beware — here are four picks whose dividends are unsustainable.

23 Biotechnology Stocks to Sell Now

This week, the overall grades of 23 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

10 Unsung Dividend Heroes With +10% Yields

Dividends are an often overlooked but crucial part of a successful retirement strategy. These quarterly offerings can provide a regular “paycheck” for retirees — especially…

5 Pharma Stocks to Buy for Big Dividends

Drugmakers aren’t known for big dividends, but the pharmaceutical industry can actually offer something for income investors.

40 Biotechnology Stocks to Sell Now

The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…

40 Biotechnology Stocks to Sell Now

This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

30 ‘Magic Formula’ Stocks for July

The ‘Magic Formula’ stock screen has beaten the market consistently over recent years — plenty of reason to consider these 30 companies for your own…

10 Stocks to Banish From Your Portfolio Forever

They all gave it “the old college try,” but Netflix, Snap, LendingClub and others were ultimately built on flawed business models.

4 Health Care Provider Stocks to Buy Now

The grades of four Health Care Provider stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an…

4 Health Care Provider Stocks to Buy Now

Four Health Care Provider stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is…

9 Health Care Provider Stocks to Buy Now

The grades of nine Health Care Provider stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an…

Why Bristol-Myers Squibb Co (BMY), Liberty Interactive Corp (QVCA) and Royal Bank of Scotland Group PLC (RBS) and Are 3 of Today’s Worst Stocks

Bristol-Myers (BMY), Liberty Interactive (QVCA) and Royal Bank of Scotland (RBS) never even had a chance of bullishness on Friday.

PolySwarm Price Predictions: Where Will the Red-Hot NCT Crypto Go Next?

Today’s interest in PolySwarm price predictions is high, as this small cryptocurrency surges approximately 30% this afternoon.

Why Is Palisade Bio (PALI) Stock Down 46% Today?

Palisade Bio (PALI) stock is falling on Thursday after the clinical-stage biopharmaceutical company announced a share offering.

5 – 10 of 240 results